Isabel E. D. G.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase III Randomized Trial of Trastuzumab, Alpelisib, and Fulvestrant Versus Trastuzumab and Chemotherapy in PIK3CA-Mutated HER2+ Advanced Breast Cancer
- Efficacy and Safety of Fezolinetant in Treating Vasomotor Symptoms in Hormone Receptor-Positive Breast Cancer Patients on Adjuvant Endocrine Therapy
- Phase II Evaluation of Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Resistant to Trastuzumab, Pertuzumab, and Taxane Therapy
Data & Insights
Has run more than one trial at 17 of 116 partner sites.
Specializations
Breast Cancer Treatment Innovation
This investigator specializes in developing advanced therapeutic approaches for HER2-positive breast cancer, with particular focus on treatment-resistant cases and novel drug combinations.
- Targeted Therapy Development
- Treatment Resistance Management
- Advanced Stage Cancer Care
Expertise extends to evaluating innovative drug combinations including trastuzumab-based therapies and emerging treatments for metastatic disease.
Precision Medicine Applications
The investigator focuses on personalized treatment approaches for patients with specific genetic markers, particularly those with PIK3CA mutations in breast cancer.
- Genetic Mutation Analysis
- Targeted Treatment Protocols
- Biomarker-Driven Therapy
Research encompasses the development of targeted therapeutic strategies for hormone receptor-positive and hormone receptor-negative breast cancer variants.
Supportive Care Innovation
The investigator studies interventions for managing treatment-related symptoms, particularly focusing on vasomotor symptoms in breast cancer patients undergoing hormone therapy.
- Quality of Life Enhancement
- Symptom Management
- Endocrine Therapy Support
Special attention is given to developing solutions for managing side effects in patients receiving adjuvant endocrine therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.